Methotrexat Sandoz 5000 mg, Konzentrat zur Herstellung einer Injektions-/Infusionslösung

7680510790290 CH-51079 Konzentrat
Methotrexat Sandoz 5000 mg, Konzentrat zur Herstellung einer Injektions-/Infusionslösung
Methotrexat Sandoz 5000 mg, Konzentrat zur Herstellung einer Injektions-/Infusionslösung
Methotrexat Sandoz 5000 mg, Konzentrat zur Herstellung einer Injektions-/Infusionslösung
1 / 3
google

Article details

Package size
1 x 50
Selling units
1
Measure
ml
Galenic form
Konzentrat
Galenic group
Tinkturen/Desinfektion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
19/03/2025
Summary of Product Characteristics
Français
19/03/2025
Summary of Product Characteristics
Italien
19/03/2025

Detailed composition

Substance Quantity Type Category
(N/A)
5.0 G Substance Wirkstoff (Principe actif)
(N/A)
- Substance WIZUS
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 358.50
Specialties list
Yes
Generic
Yes
SL addition date: 01/04/2002

Authorization holder

Sandoz Pharmaceuticals AG

6343 Risch

Authorization information

Swissmedic authorization number
51079
Drug name
Methotrexat Sandoz, Konzentrat zur Herstellung einer Injektions-/Infusionslösung
Galenic form
KOPA
ATC Code
L01BA01
Authorization status
Z
Dispensing category
A
First authorization
15/11/1994
Authorization expiration date
31/12/9999
IT Number
07.16.1.
Domain
Human medicine
Field of application
Zytostatikum

Package details

Description (FR)
METHOTREXATE Sandoz conc perf 5000 mg flac 50 ml
Description (DE)
METHOTREXAT Sandoz Inf Konz 5000 mg Durchstf 50 ml
Market launch
15/11/1994
Narcotic (BTM)
No

Other package sizes (3)

METHOTREXAT Ebewe conc perf 1 g flac 10 ml
None None
GTIN: 7680510790191
Not in V1
METHOTREXATE Sandoz conc perf 1000 mg flac 10 ml
1 x 10 ML
GTIN: 7680510790283
View
METHOTREXAT Ebewe conc perf 5 g flac 50 ml
None None
GTIN: 7680510790276
Not in V1